Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01817361 · ClinicalTrials.gov registry record
Oral Health and People With Systemic Sclerosis
A clinical trial of Systemic Sclerosis, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- 210
- Enrollment target
- 1
- Study location
NCT01817361 is a study of Systemic Sclerosis that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 210 participants, below the 271-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01817361, a study of Systemic Sclerosis, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
- 1
- Study location
Study Summary
The public health impact of this study will be the application of the greater understanding of the oral health status, oral health related behaviors, and quality of life of patients with systemic sclerosis (scleroderma or SSc). It is hoped that risks and protective factors can be identified to be associated with the oral health status of adults with systemic sclerosis,leading to the development of interventions for improved oral health in this population,and providing the basis for a larger study of oral health problems of adults with systemic sclerosis.
Conditions Studied
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2007-10 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01817361
The ClinicalTrials.gov registry entry for NCT01817361 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 271-participant average among 26 other Systemic Sclerosis trials with a reported enrollment target (23% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Systemic Sclerosis appearing as the primary indexed condition, and to 0 interventions.
NCT01817361 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.
Frequently Asked Questions
What is clinical trial NCT01817361 about?
NCT01817361 is a clinical study titled "Oral Health and People With Systemic Sclerosis". The public health impact of this study will be the application of the greater understanding of the oral health status, oral health related behaviors, and quality of life of patients with systemic sclerosis (scleroderma or SSc). It is hoped that risks and protective factors can be identified to be as...
What is the current status of trial NCT01817361?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2007-10. Estimated completion is 2010-06.
What conditions does trial NCT01817361 study?
This clinical trial studies the following conditions: Systemic Sclerosis.
Who is sponsoring clinical trial NCT01817361?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01817361 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systemic Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
RECRUITING · Phase 2
-
Interrogating the Pathophysiological Mechanisms of Constipation in Patients With Systemic Sclerosis
RECRUITING · NA
-
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RECRUITING · Phase 1
-
A Study of AZD0120 in Autoimmune Diseases
RECRUITING · Phase 1
-
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
RECRUITING · Phase 1
-
New Orleans Pulmonary Hypertension Biobank
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.